\
&
Contact us
\
&
Contact us
Starts in 1 week from now
LocationOnline
ProgrammesAre you currently preparing a Horizon EU proposal wit a submission deadline mid April in the domains DATA, DIGITAL-EMERGING or HUMAN?
Interested in a free quality check before you submit? Then the online Ideal-ist Digital 2026 Spring Proposalcheck Event is for you!
A proposal check event offers proposers a chance to improve the quality of project proposals based on feedback from experienced external experts and national contact points (NCPs). The event aims to transfer useful knowledge and increase proposers' chances for funding.
Registration and early draft submission is required by 6 March 2026 (but do is as soon as possible), with selection confirmation occurring between 9 and 13 March 2026. The event is not first come first served, only the best proposals will be selected.
The initiative aims to provide personalized expert feedback, helping participants identify strengths and weaknesses in the selected proposals to improve evaluation scores. For further details, visit https://digital2026spring.proposalcheck.eu/.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
